₹52.05
▼ -2.73 -4.98%
17 Jul 2026
BSE Listed
Bervin Investment & Leasi (531340)
Volume: 88Avg Vol 1W: 118Avg Vol 1M: 53552W Range:₹37.75₹73.5
Key Ratios
Checked just nowMarket Cap₹31 Cr
Current Price₹52.05
Previous Close₹54.78
High / Low (52w)₹73.5 / ₹37.75
Volume88
Avg Vol (1W)118
Avg Vol (1M)535
Stock P/E—
Book Value₹31.87
Dividend Yield0%
ROE-83.34%
ROA-68.22%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B1.63
Debt / Equity0.72
50 DMA₹53.55
200 DMA₹56.31
Day change-4.98%
Price Chart
₹52.05▼ 12.52% · 1Y
2025-07-162026-07-16
20-day avg volume: 435 shares
Pros
- Company is almost debt-free.
- Revenue grew 50% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| EBITDA | — | — | — | — | — | — | — | — |
| Net Profit | ₹2 Cr | ₹2 Cr | ₹-6 Cr | ₹1 Cr | ₹-17 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹20 Cr | ₹7 Cr | ₹11 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹14 Cr | ₹1 Cr | ₹4 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹11 Cr | ₹1 Cr | ₹3 Cr |
| EPS | 0 | 0 | 0.03 | -0.02 | 18.86 | 1.37 | 7.04 |
Balance Sheet
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹10 Cr | ₹8 Cr | ₹10 Cr | ₹27 Cr | ₹41 Cr | ₹41 Cr | ₹35 Cr |
| Total Liabilities | ₹8 Cr | ₹7 Cr | ₹6 Cr | ₹21 Cr | ₹23 Cr | ₹25 Cr | ₹11 Cr |
| Equity | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹6 Cr | ₹18 Cr | ₹15 Cr | ₹24 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-34 Cr | ₹10 Cr | ₹8 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹-2 Cr | ₹-16 Cr | ₹34 Cr | ₹-11 Cr | ₹1 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹15 Cr | ₹-1 Cr | ₹5 Cr | ₹-14 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-34 Cr | ₹10 Cr | ₹8 Cr |
Shareholding
Promoter 73.55% Institutions 0% Public 26.45%
Efficiency & Working Capital
ROCE-65.9%
Interest Coverage7.6
Dividend Payout—
Debtor Days76 d
Inventory Days178 d
Payable Days114 d
Cash Conversion Cycle140 d
Working Capital Days254 d
Shareholding Details
As of 2026-06-30
Promoter73.6%
FII0%
DII0%
Institutions0%
Public26.4%
Promoter Pledge0%
No. of Shareholders1,524
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% | 73.6% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% | 26.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,288 | 1,294 | 1,287 | 1,306 | 1,347 | 1,536 | 1,553 | 1,537 | 1,529 | 1,505 | 1,492 | 1,524 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sushma Paul Berlia | Shareholding of Promoter and Promoter Group | 27.9% | 16,44,658 |
| Chang Investchem Pvt Ltd | Shareholding of Promoter and Promoter Group | 19.9% | 11,73,000 |
| Neha Vijay Kumar Berlia | Shareholding of Promoter and Promoter Group | 15.4% | 9,09,700 |
| Martin And Harris Laboratories Ltd | Public Shareholding | 9.9% | 5,81,000 |
| Selucon Private Limited | Shareholding of Promoter and Promoter Group | 9.5% | 5,60,000 |
| Sunil Lamba | Public Shareholding | 2% | 1,14,785 |
| Hitesh Ramji Javeri | Public Shareholding | 1.9% | 1,10,928 |
| Sudha Satyanarayan Berlia | Shareholding of Promoter and Promoter Group | 0.9% | 50,038 |
| Aditya Berlia | Shareholding of Promoter and Promoter Group | 0% | 500 |
| Nishant Berlia | Shareholding of Promoter and Promoter Group | 0% | 250 |
| Kusum Rekhi | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Sushma Paul Berlia | 0 | 0% | 2026-06-30 |
| Neha Vijay Kumar Berlia | 0 | 0% | 2026-06-30 |
| Sudha Satyanarayan Berlia | 0 | 0% | 2026-06-30 |
| Aditya Berlia | 0 | 0% | 2026-06-30 |
| Nishant Berlia | 0 | 0% | 2026-06-30 |
| Kusum Rekhi | 0 | 0% | 2026-06-30 |
| Chang Investchem Pvt Ltd | 0 | 0% | 2026-06-30 |
| Selucon Private Limited | 0 | 0% | 2026-06-30 |
| Hitesh Ramji Javeri | 0 | 0% | 2026-06-30 |
| Sunil Lamba | 0 | 0% | 2026-06-30 |
| Martin And Harris Laboratories Ltd | 0 | 0% | 2026-06-30 |
| Sushma Paul Berlia | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| S K Murgai | Non-Exec & Non-Independent Dir | 2025 |
| Kalpana Umakanth | Non Executive Director / Company Secretary | 2025 |
| Vivek Manohar Padgaonkar | Independent Non Exe. Director | 2025 |
| Ashok Ogra | Independent Non Exe. Director | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 7 | 6 | 6 |
Substantial Acquisitions (SAST)
4 disclosure(s)
Inter-se Transfer28/03/2024 · 2,60,700
-28/03/2024 · 2,60,700
Inter-se Transfer28/03/2024 · 2,60,700
NULL28/03/2024 · 2,60,700
Company Information
🌐 www.bervin.com ↗
📍 607 Rohit House, 3 Tolstoy Marg, New Delhi, New Delhi, 110001
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search